Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - OPERATING INCOME
Operating Income VRDN - Viridian Therapeutics, Inc.
-254 M
LAST VALUE
-78.65%
2 YEAR CAGR
-50.38%
5 YEAR CAGR
-104.78%
10 YEAR CAGR